Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
9.88
+0.08 (0.82%)
Dec 15, 2025, 11:26 AM EST - Market open
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $31.39 million as of December 15, 2025. Its market cap has decreased by -32.33% in one year.
Market Cap
31.39M
Enterprise Value
2.70M
1-Year Change
-32.33%
Ranking
Category
Stock Price
$9.88
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $31.39M, a decrease of -96.72%. That is a compound annual growth rate of -44.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 31.14M | -11.11% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |